Search results
Results from the WOW.Com Content Network
The first ultra-high-yield dividend stock that makes for a no-brainer buy in the upcoming year is pharmaceutical juggernaut Pfizer (NYSE: PFE). Though Pfizer has been weighed down by shrinking ...
That's more than enough to buy one share of Pfizer (NYSE: PFE), which currently trades below $27 per share. Pfizer's current forward dividend yield of 6.5% is near its highest level in 15 years.
High-yield dividend stocks may not appeal to some investors. Three Motley Fool contributors have identified some especially great high-yield dividend stocks to buy in 2025 -- and all of them are ...
Its payout ratio of 98.5% is high, but I think the dividend is relatively safe. The company should be able to deliver long-term operating earnings-per-share growth of between 5% and 7%, enough to ...
Components are added when they reach the 25-year threshold and are removed when they fail to increase their dividend during a calendar year or are removed from the S&P 500. However, a study found that the stock performance of companies improves after they are removed from the index. [2]
The falling share price has pushed the stock's dividend yield to nearly 6%. There are signs though that the reduced-performance pain may be nearing an end. Catalysts in the drug production ...
When trouble hits, the first instinct is to run but if you insist on holding your ground, you might want to consider pivoting your funds toward safe dividend stocks to buy.
For premium support please call: 800-290-4726 more ways to reach us